These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30034252)

  • 1. Concurrent weekly single cisplatin vs triweekly cisplatin alone with radiotherapy for treatment of locally advanced cervical cancer: a meta-analysis.
    Zhu J; Ji S; Hu Q; Chen Q; Liu Z; Wu J; Gu K
    Cancer Manag Res; 2018; 10():1975-1985. PubMed ID: 30034252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weekly versus triweekly cisplatin-based concurrent chemoradiotherapy in the treatment of locally advanced cervical carcinoma: An updated meta-analysis based on randomized controlled trials.
    Zhu J; Zhang Z; Bian D; Chen Q; Hu Q; Ji S; Gu K
    Medicine (Baltimore); 2020 Jan; 99(1):e18663. PubMed ID: 31895831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiotherapy with concurrent cisplatin-based doublet or weekly cisplatin for cervical cancer: a systematic review and meta-analysis.
    Petrelli F; De Stefani A; Raspagliesi F; Lorusso D; Barni S
    Gynecol Oncol; 2014 Jul; 134(1):166-71. PubMed ID: 24793000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized clinical trial of weekly vs. triweekly cisplatin-based chemotherapy concurrent with radiotherapy in the treatment of locally advanced cervical cancer.
    Ryu SY; Lee WM; Kim K; Park SI; Kim BJ; Kim MH; Choi SC; Cho CK; Nam BH; Lee ED
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e577-81. PubMed ID: 21840137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Weekly Versus Triweekly Cisplatin-Based Chemotherapy Concurrent With Radiotherapy in the Treatment of Cervical Cancer: A Meta-Analysis.
    Chen X; Zou H; Li H; Lin R; Su M; Zhang W; Zhou Y; Zhang P; Hou M; Deng X; Zou C
    Int J Gynecol Cancer; 2017 Feb; 27(2):344-349. PubMed ID: 27984377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weekly versus triweekly cisplatin treatment in patients with locally advanced nasopharyngeal cancer during concurrent chemoradiotherapy.
    Li X; Li L; Sun R; Gao J; Li Z; Xue Y; Zhu L; Xu T; Sun C; Xi Y; Xiong W
    Eur J Med Res; 2023 Oct; 28(1):399. PubMed ID: 37794519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evidence on effectiveness of weekly vs triweekly cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell carcinoma (HNSCC): a systematic review and meta-analysis.
    Jacinto JK; Co J; Mejia MB; Regala EE
    Br J Radiol; 2017 Nov; 90(1079):20170442. PubMed ID: 29053029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent weekly cisplatin versus triweekly cisplatin with radiotherapy for locally advanced squamous-cell carcinoma of the cervix: a retrospective analysis from a single institution.
    Kinjyo Y; Nagai Y; Toita T; Kudaka W; Ariga T; Shimoji Y; Nakasone T; Taira Y; Arakaki Y; Nakamoto T; Wakayama A; Ooyama T; Maemoto H; Heianna J; Aoki Y
    Br J Radiol; 2017 Aug; 90(1076):20170241. PubMed ID: 28707541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weekly versus triweekly cisplatin-alone adjuvant chemoradiotherapy after radical hysterectomy for stages IB-IIA cervical cancer with risk of recurrence.
    Zhu J; Lou R; Ji S; Wu G; Chen Q; Hu Q; Zhao Y; Cai D; Gu K
    Anticancer Drugs; 2021 Feb; 32(2):203-209. PubMed ID: 33186140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of weekly versus triweekly cisplatin delivered concurrently with radiation therapy in patients with locally advanced nasopharyngeal cancer: A multicenter randomized phase II trial (KCSG-HN10-02).
    Lee JY; Sun JM; Oh DR; Lim SH; Goo J; Lee SH; Kim SB; Park KU; Kim HK; Hong DS; Kim JS; Kim SG; Yi SY; Yun HJ; Hyun MS; Kim HJ; Jung SH; Park K; Ahn YC; Ahn MJ
    Radiother Oncol; 2016 Feb; 118(2):244-50. PubMed ID: 26705681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of weekly versus triweekly cisplatin concurrent with radiotherapy in nasopharyngeal carcinoma: A meta-analysis.
    Chen L; Li YC; Hu M; Zhao SJ; Yang QW
    Medicine (Baltimore); 2022 Dec; 101(52):e31842. PubMed ID: 36596073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Weekly cisplatin therapy compared with triweekly combination chemotherapy as concurrent adjuvant chemoradiation therapy after radical hysterectomy for cervical cancer.
    Lee HN; Lee KH; Lee DW; Lee YS; Park EK; Park JS
    Int J Gynecol Cancer; 2011 Jan; 21(1):128-36. PubMed ID: 21330837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of weekly versus triweekly cisplatin treatment concomitant with radiotherapy for locally advanced nasopharyngeal carcinoma: A systematic review and pooled analysis.
    Tian X; Zhu Q; Zhang Z
    Front Pharmacol; 2022; 13():999027. PubMed ID: 36686714
    [No Abstract]   [Full Text] [Related]  

  • 14. Concurrent weekly cisplatin versus triweekly cisplatin with radiotherapy in the treatment of cervical cancer: a meta-analysis result.
    Hu Y; Cai ZQ; Su XY
    Asian Pac J Cancer Prev; 2012; 13(9):4301-4. PubMed ID: 23167332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective Analysis of Concurrent Chemoradiation with Triweekly Cisplatin plus 5-Fluorouracil Versus Weekly Cisplatin in Cervical Cancer.
    Sonoda K; Yahata H; Ichinoe A; Okugawa K; Kaneki E; Kawano Y; Kenjo H; Ohgami T; Yagi H; Ohga S; Asai K; Nakamura K; Honda H; Kato K
    Anticancer Res; 2015 Jun; 35(6):3447-54. PubMed ID: 26026109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of weekly and triweekly cisplatin regimens during concurrent chemoradiotherapy for nasopharyngeal carcinoma.
    Wang K; Dong J; He S; Wang X; Jiang C; Hu P; Guo J; Cai X; Wang X
    BMC Cancer; 2019 May; 19(1):482. PubMed ID: 31117967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten years survival results of randomized study comparing weekly
    Nanda R; Katke A; Thejaswini B; Giri GV; Pawar Y; Manjula MV; Babu G
    Rep Pract Oncol Radiother; 2023; 28(3):322-331. PubMed ID: 37795405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weekly versus triweekly cisplatin plus intensity-modulated radiotherapy in locally advanced nasopharyngeal carcinoma: A propensity score analysis with a large cohort.
    Zhu Q; Hu H; Tang LQ; You R; Zhao JJ; Weng DS; Pan QZ; Chen CL; Zhou ZQ; Tang Y; Xia JC
    J Cancer; 2018; 9(19):3447-3455. PubMed ID: 30310501
    [No Abstract]   [Full Text] [Related]  

  • 19. Weekly versus triweekly cisplatin-based concurrent chemoradiotherapy for nasopharyngeal carcinoma: a systematic review and pooled analysis.
    Tang J; Zou GR; Li XW; Su Z; Cao XL; Wang BC
    J Cancer; 2021; 12(20):6209-6215. PubMed ID: 34539894
    [No Abstract]   [Full Text] [Related]  

  • 20. Platinum single-agent vs. platinum-based doublet agent concurrent chemoradiotherapy for locally advanced cervical cancer: A meta-analysis of randomized controlled trials.
    Ma S; Wang J; Han Y; Guo F; Chen C; Chen X; Zou W
    Gynecol Oncol; 2019 Jul; 154(1):246-252. PubMed ID: 31005286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.